As the Philippines FDA resumes foreign Good Manufacturing Practice (GMP) inspections following Advisory No. 2024-0542, drug manufacturers face a pivotal moment to ensure compliance and enhance their operational standards. Triple I specializes in regulatory compliance, guiding you through the complexities of these inspections to ensure a smooth process.
With the World Health Organization’s declaration that COVID-19 is no longer a public health emergency, the FDA will begin issuing inspection schedules in March 2024, with actual inspections starting in April. This is your ultimate opportunity to showcase your commitment to quality and regulatory compliance.
Our expert team will assist you in various aspects such as documentation practices of your GMP credentials, ensuring:
- Cleanliness and maintenance
- Equipment calibration and maintenance
- Personnel training and hygiene
- and Quality control processes that align with FDA standards.
We’ll help you establish effective communication with the FDA and address any compliance concerns proactively. Contact us through any of the following channels below to schedule an initial consultation with one of our FDA experts:
- Contact Us Here
- Fill out the form below
- Call us at: +63 (02) 8540-9623
- Send an email to: info@tripleiconsulting.com
